跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOLPAZA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NOLPAZA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG
Approved
STANDARD
NOLPAZA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG
Krka D.D. Novo Mesto
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 1, 2020
Approval ID
272fd50c87db8fbc
Company
Krka D.D. Novo Mesto
Type
Standard
Approval Details
Approval Id
272fd50c87db8fbc
Drug Cima Aemps Name
NOLPAZA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG
Register Number
14135
Holder Company Name
Krka D.D. Novo Mesto
Marketing Company Name
Elam Pharma Labs S.L.
Authorization Date
2020-10-01
Dosage Form
COMPRIMIDO GASTRORRESISTENTE
Dose
40 MG
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Krka D.D. Novo Mesto
Active Ingredients
PANTOPRAZOL SODICO SESQUIHIDRATO
45,1 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 1, 2020
Approval ID
272fd50c87db8fbc
Type
Standard
Back to CIMA-AEMPS Approvals
